**Strong IPO momentum in late 2026, anchored by Anthropic’s planned $61 billion Nasdaq offering priced around November 19, has driven elevated trader expectations for activity before year-end.** Multiple deals have already priced in mid-November, including Windward Bio Group (WWB) and vVARDIS Holding (VVVV) at $175 million each, alongside smaller U.S. and international listings such as Bluerock Acquisition Corp. II. Recent data show 83 traditional IPOs raising over $120 billion through September, with the fourth-quarter pipeline—including AI and biotech issuers—supported by robust order books and a rebound in the IPOX index. Key catalysts ahead include additional November pricings and potential December filings, though execution remains sensitive to equity volatility, Treasury yields, and AI valuation scrutiny. This activity reflects skin-in-the-game consensus that the window stays open through December.
Riepilogo sperimentale generato dall'AI con riferimento ai dati di Polymarket. Questo non è un consiglio di trading e non ha alcun ruolo nella risoluzione di questo mercato. · Aggiornato1H6H1D7D30DALL
View resolved





























Fai attenzione ai link esterni.
Fai attenzione ai link esterni.
Domande frequenti